中华医学会第十七次全国病毒性肝炎及肝病学术会议暨2015年中华医学会感染病学分会年会、中华医学会肝病学分会年会日程 |
|
|
|
|
时 间 | | | |
10月23日(周五) |
09:00-21:00 | |
继续教育课程:黄疸待查——黃疸的诊断与鉴别诊断(一层大宴厅A) |
14:00-14:20 | | | |
14:20-14:50 | | |
14:50-15:20 | | |
15:20-15:50 | | |
15:50-16:00 | |
16:00-16:30 | | |
16:30-17:00 | | |
| |
17:05-18:05 | | | |
| |
| |
18:05-18:55 | | | |
| |
10月24日(周六)上午 |
主会场 (四层大会堂A) |
| |
08:00-08:05 | | | |
08:05-08:13 | | |
08:13-08:21 | |
|
08:21-08:30 | |
|
08:30-08:50 | |
|
| |
08:50-09:10 | | | |
09:10-09:30 | Taking public health action on viral hepatitis - the WHO global hepatitis strategy | |
09:30-09:45 | | |
09:45-10:00 | | |
10:00-10:15 | | |
10:15-10:30 | | |
10:30-10:40 | |
| 专题学术研讨会3:慢性乙型肝炎指南及病例演讲全国总决赛(评委:侯金林、魏来、贾继东、陈成伟、高志良) |
10:40-10:45 | | | |
10:45-10:50 | | |
10:50-11:00 | | |
11:00-11:10 | | |
11:10-11:20 | | |
11:20-11:30 | | |
11:30-11:35 | 打分和点评 魏 来、侯金林、贾继东、陈成伟、高志良 |
11:35-11:38 | | |
11:38-11:40 | |
|
| |
11:40-12:40 | | | |
2.派格宾治疗中国HBeAg阳性慢性乙型肝炎的疗效和安全性研究 | |
10月24日(周六)下午 |
主会场 乙肝<1>专题 (四层大会堂A) |
| |
13:20-13:35 | | | |
13:35-13:50 | | |
13:50-14:05 | 慢性乙型肝炎抗病毒治疗疗效预测的免疫学指标研究进展 | |
14:05-14:20 | | | |
14:20-14:35 | | |
| 大会报告学术交流1 (优秀论文评选评委:王贵强、盛吉芳、董蕾、窦晓光、宁琴、戴炜、于岩岩、孟庆华、王凯、 张伦理、谢尧、刘晓清、谢雯、邓存良、彭劼、孙剑、张小勇) |
14:35-14:45 | ALT正常HBV DNA阳性的慢性HBV感染者抗病毒治疗时机的探讨 | | |
14:45-14:55 | Telbivudine reduces adverse pregnancy outcomes in singletons borne to high HBV viremic mothers | |
14:55-15:05 | 中国乙型肝炎防治经济学:决策分析Markov模型构建和应用 | |
15:05-15:15 | 替诺福韦酯挽救治疗既往对NAs治疗耐药的慢性乙型肝炎的疗效分析 | | |
15:15-15:25 | Comparison of the renal protective effect of telbivudine and other nucleos(t)ide analogues in patients with chronic hepatitis B: a systematic review | |
15:25-15:35 | 非活动性HBsAg携带者抗病毒治疗疗效及安全性研究 | |
15:35-15:45 | Quantitative intrahepatic HBV cccDNA correlates with histological liver inflammation activity in chronic hepatitis B infection: A cohort study | | |
15:45-15:55 | HBeAg阳性慢性乙型肝炎患者HBV前C/BCP突变与血清HBeAg和HBV DNA水平相关性研究 | |
15:55-16:05 | The efficacy and safety of telbivudine and/or tenofovir disoproxil in pregnancy for prevention of mother-to-child transmission of hepatitis B virus | |
16:05-16:15 | | |
| |
16:15-16:35 | | | |
16:35-16:45 | |
| |
16:45-17:35 | | | |
| |
| |
| “中国慢性乙型肝炎诊疗现状调查项目”及“中国慢性丙型肝炎诊疗现状调查项目”发布会 |
17:35-17:40 | | | |
17:40-18:10 | | |
18:10-18:40 | | |
分会场一 丙肝专题(一层大宴厅A) |
| |
13:20-13:35 | | | |
13:35-13:50 | | |
13:50-14:05 | | |
14:05-14:20 | | | |
14:20-14:35 | | |
| 大会报告学术交流2 (优秀论文评选评委:魏来、南月敏、李太生、谢青、尚佳、徐小元、陈新月、江建宁、曹武奎、刘娅、 林明华、李智伟、赵龙凤、刘正印、傅青春、范建高、李兴旺、王峰、李成忠、胡鹏、曹红翠) |
14:35-14:45 | UNITY1 III期临床研究结果:全口服固定剂量复方制剂(daclatasvir, asunaprevir和 beclabuvir ) 治疗慢性丙型肝炎基因1型非肝硬化患者 | | |
14:45-14:55 | 采用索菲布韦(Sofosbuvir, SOF)和利巴韦林治疗伴有HCV GT1-4型共感染的HIV患者:PHOTON-1和-2试验 | |
14:55-15:05 | 2型或3型HCV感染患者用索菲布韦(Sofosbuvir,SOF)+利巴韦林治疗12周或24周:VALENCE试验 | |
15:05-15:15 | 对于HCV 3型患者和经治肝硬化的HCV 2型V患者,采用索菲布韦(Sofosbuvir,SOF)+聚乙二醇干扰素/利巴韦林方案治疗12周与索菲布韦+利巴韦林方案治疗16周或24周的比较: BOSON研究 | | |
15:15-15:25 | NEUTRINO索菲布韦(Sofosbuvir,SOF)+聚乙二醇干扰素+利巴韦林方案12周治疗初治1、4、5和6型丙型肝炎病毒(HCV)感染患者SVR12为90%:NEUTRINO研究 | |
15:25-15:35 | HIV合并HCV感染者抗HCV最佳时机和方案的探讨 | |
15:35-15:45 | 慢性HCV GT2型 感染的韩国和台湾患者采用索菲布韦(Sofosbuvir,SOF)+利巴韦林方案治疗12周SVR12为98%:来自一项国际多中心3期研究结果 | | |
15:45-15:55 | The impact of pegylated interferon for treatment of HCV in far-stage liver cancer: a systematic review and meta analysis | |
15:55-16:05 | 对HCV 1型经治感染患者采用索菲布韦(Sofosbuvir, SOF)再治疗的耐药性分析 | |
16:05-16:15 | 全口服双药联合(daclatasvir和asunaprevir)治疗韩国和台湾慢性丙型肝炎基因1b型患者 | |
| |
16:15-16:35 | | | |
分会场二 2015肝病临床思维训练营-全国肝病病例竞赛总决赛 (3层报告厅) |
点评专家(九大赛区主席及晋级总决赛选手医院指导专家):董玲、范学工、封波、高志良、韩涛、黄燕、李军、陆伦根、吕芳芳、任万华、唐红、王丽春、吴静、阎明、俞云松、张文宏 |
13:20-13:25 | | | |
13:25-13:30 | | |
13:30-13:40 | | |
13:40-14:40 | | |
14:40-14:55 | |
14:55-15:55 | |
15:55-16:10 | |
16:10-16:25 | |
16:25-16:30 | |
16:30-16:40 | | |
分会场三 肝纤维化、肝硬化及肝衰竭专题 (1层多能厅C) |
| |
13:20-13:35 | 肝硬化门静脉高压食管胃静脉曲张出血的防治指南发布仪式 | | |
13:35-13:50 | 肝硬化门静脉高压食管胃静脉曲张出血的防治指南(解读) | | |
13:50-14:05 | | |
14:05-14:20 | | |
14:20-14:35 | | | |
14:35-14:50 | | |
14:50-15:05 | | |
15:05-15:20 | | | |
15:20-15:35 | | |
| 大会报告学术交流3 (优秀论文评选评委:徐小元、成军、甘建和、李玉芳、聂玉强、李树臣、路青华、马雄、蔺淑梅、江应安、王磊、左维泽、茅益民、石荔、李威) |
15:35-15:45 | Combining routine markers improves the accuracy of transient elastography for hepatitis B cirrhosis detection | | |
15:45-15:55 | Umbilical cord blood stem cell transplantation for the treatment of decompensated cirrhosis | |
15:55-16:05 | | |
16:05-16:15 | 脓毒血症(sepsis)对乙肝后肝硬化急性失代偿患者重症化为慢加急性肝衰竭的临床研究 | |
| |
16:15-16:35 | | | |
第三天10月25日(周日) 上午 |
主会场 其他肝病专题 (四层大会堂A) |
| |
08:00-08:15 | | | |
08:15-08:30 | | |
08:30-08:45 | | |
08:45-09:00 | | |
09:00-09:15 | | |
| 大会报告学术交流4 (优秀论文评选评委:魏来、贾继东、尤红、韩英、马雄、黄祖瑚 李用国 龚国忠、倪武、陆伟、 唐小平、范学工、赵敏、蔡伟) |
09:15-09:25 | Regulatory T cells prevent alcohol-induced hepatic steatosis in mice | | |
09:25-09:35 | Upregulated expression of SENP3 plays an important role in lipid metabolism pathway in non-alcoholic fatty liver disease | |
09:35-09:45 | Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding | |
09:45-09:55 | | |
主会场 乙肝<2>专题 (四层大会堂A) |
| 大会报告学术交流5 (优秀论文评选评委:魏来、贾继东、尤红、韩英、马雄、黄祖瑚 李用国 龚国忠、倪武、陆伟、 唐小平、范学工、赵敏、蔡伟) |
09:55-10:05 | | | |
10:05-10:15 | 深度测序分析基线乙型肝炎病毒逆转录酶区准种特性对抗病毒治疗疗效的预测能力 | |
10:15-10:25 | Downregulation of TLR2 on CD14+ monocytes and upregulation of PD-1 on CD8+T cells correlate with virological breakthrough in entecavir suppressed CHB patients with sequential peginterferon alfa treatment | |
10:25-10:35 | Altered expression of STAT1, MX and SOCS3 associated strongly with outcome of therapy in HBV infection | |
10:35-10:45 | 人核苷转运蛋白1(hCNT1/SLC28A1)、多药耐药蛋白4(MRP4/ABCC4)及多药耐药蛋白5(MRP5/ABCC5)基因多态性对慢性乙型肝炎核苷类似物抗病毒治疗应答的影响 | | |
10:45-10:55 | Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China | |
10:55-11:05 | A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China | |
| |
11:05-11:25 | | | |
| |
11:25-11:45 | | | |
分会场一 微生态专题、妊娠肝病专题 (一层大宴厅A) |
| |
08:00-08:25 | | | |
08:25-08:50 | | |
08:50-09:15 | | |
| |
09:15-09:30 | | | |
09:30-09:45 | | |
09:45-10:00 | | |
10:00-10:15 | 慢性HBV感染孕妇妊娠后期应用替比夫定婴儿长期安全性研究 | | |
10:15-10:30 | | |
| |
10:30-10:50 | | | |
| |
10:50-11:10 | | | |
分会场二 肝衰竭、肝癌多学科合作专题 (3层报告厅) |
| |
08:00-08:15 | | | |
08:15-08:30 | | |
08:30-08:45 | | |
08:45-09:00 | | |
09:00-09:15 | | |
| 大会报告学术交流6 (优秀论文评选评委:段钟平、韩涛、徐列明、韦嘉、赵英仁、赵彩彦、魏少峰、张专才、王者令、宣世英、吴君、陈柏义) |
09:15-09:25 | Lipid microbubbles loaded docetaxel (LDLM) combined With ultrasound-targeted microbubble destruction inhibits the proliferation and induces the apoptosis of SMMC-7721 hepatocellular carcinoma cell | | |
09:25-09:35 | 全基因组关联研究鉴定的12个候选单核苷酸多态性位点与肝细胞癌发生风险相关性的队列研究 | |
09:35-09:45 | 射波刀联合肝动脉化疗栓塞治疗原发性肝癌的疗效及预后分析 | | |
09:45-09:55 | Failure recovery of circulating NKG2D+CD56dim NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence | |
09:55-10:05 | Inhibition of GSK3beta promotes autophagy to protect mice from acute liver failure mediated by PPAR alpha | |
10:05-10:15 | 甲基强的松龙治疗HBV相关慢加急性肝衰竭疗效及安全性的前瞻性队列研究 | |
10:15-10:25 | | | |
10:25-10:35 | Risk factors for liver failure from immunosuppressive therapy-induced hepatitis B virus reactivation | |
10:35-10:45 | Increased TLR2 expression in peripheral CD4+ T cells promotes Th17 cells responses and is associated with disease aggravation of HBV-related acute-on-chronic liver failure | |
10:45-10:55 | Viral suppression and regression of HBV-induced liver fibrosis: a preliminary data of a randomized, controlled, prospective 2-years study | |
| |
10:55-11:15 | Effect of silymarin on liver health and quality of life | | |
分会场三 肝病基础专题 (1层多能厅C) |
| |
08:00-08:15 | | | |
08:15-08:30 | | |
08:30-08:45 | | |
08:45-09:00 | | | |
09:00-09:15 | | |
09:15-09:30 | 新一代测序技术在乙肝病毒感染研究中的应用及其临床意义 | |
| 大会报告学术交流7 (优秀论文评选评委:任红、张岭漪、李佳、陈智、余祖江、毛青、谭德明、陈永平、张大志、 高人焘、黄缘、陈良、陈红松) |
09:30-09:40 | HMGB1通过NF-kB信号通路调控上皮间质转化影响原发性肝细胞癌的侵袭 | | |
09:40-09:50 | 乙型肝炎病毒(HBV)与戊型肝炎病毒(HEV)在细胞培养中相互作用的研究 | |
09:50-10:00 | 分泌型HBV RNA可能是HBV难以清除的一个因素 | |
10:00-10:10 | 慢性乙型肝炎进程中分泌IL-10的调节性B细胞对效应性T细胞及调节性T细胞功能的调控 | | |
10:10-10:20 | Transforming growth factor β-activated kinase 1 inhibits HBV replication and gene expression through MAPK-JNK pathway | |
10:20-10:30 | Salvia Miltiorrhiza inhibits liver fibrosis via promoting functions of hepatic natural killer cells | |
10:30-10:40 | 慢乙肝患者肝活检中HBV cccDNA及相关复制中间体的原位杂交分析 | | |
10:40-10:50 | Inhibition of HBV cccDNA transcription by CPP-PNA conjugates assembled on an oligonucleotide scaffold | |
| |
11:00-11:20 | | | |
第三天10月25日(周日) 下午 |
主会场 (四层大会堂A) |
| |
12:30-13:30 | | | |
| |
| 2015年版《中国慢性乙型肝炎防治指南》和《丙型肝炎防治指南》发布会 |
13:30-13:45 | 2015年版《中国慢性乙型肝炎防治指南》和《丙型肝炎防治指南》发布致辞 | | |
13:45-14:05 | | |
14:05-14:15 | |
|
14:15-14:35 | | |
14:35-14:45 | |
|
14:45-15:00 | 2015年版《中国慢性乙型肝炎防治指南》和《丙型肝炎防治指南》发布仪式 |
|
| |
15:00-15:20 | |
| 魏来 |
15:20-15:30 | | |
|
|
|
|
|